Direkt zum Inhalt
Merck

X-ray crystallographic structure of RNase Po1 that exhibits anti-tumor activity.

Biological & pharmaceutical bulletin (2014-06-03)
Hiroko Kobayashi, Takuya Katsutani, Yumiko Hara, Naomi Motoyoshi, Tadashi Itagaki, Fusamichi Akita, Akifumi Higashiura, Yusuke Yamada, Norio Inokuchi, Mamoru Suzuki
ZUSAMMENFASSUNG

RNase Po1 is a guanylic acid-specific ribonuclease member of the RNase T1 family from Pleurotus ostreatus. We previously reported that RNase Po1 inhibits the proliferation of human tumor cells, yet RNase T1 and other T1 family RNases are non-toxic. We determined the three-dimensional X-ray structure of RNase Po1 and compared it with that of RNase T1. The catalytic sites are conserved. However, there are three disulfide bonds, one more than in RNase T1. One of the additional disulfide bond is in the catalytic and binding site of RNase Po1, and makes RNase Po1 more stable than RNase T1. A comparison of the electrostatic potential of the molecular surfaces of these two proteins shows that RNase T1 is anionic whereas RNase Po1 is cationic, so RNase Po1 might bind to the plasma membrane electrostatically. We suggest that the structural stability and cationic character of RNase Po1 are critical to the anti-cancer properties of the protein.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
IPTG, ≥99% (TLC), ≤0.1% Dioxane
Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Isopropyl β-D-1-Thiogalactopyranosid, ≥99% (TLC)
Sigma-Aldrich
Isopropyl-β-D-thiogalactopyranosid -Lösung, ReadyMade IPTG solution for Blue-white screening
Supelco
Ampicillin
SAFC
Isopropyl β-D-1-Thiogalactopyranosid
Sigma-Aldrich
Ampicillin, meets USP testing specifications
USP
Ampicillin, United States Pharmacopeia (USP) Reference Standard
Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard